Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004134 (
ataxia
)
15,886
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Background:
Huntington's disease (HD) is a progressive disorder characterized by motor, cognitive and psychiatric features. Cerebellar ataxia is classically considered as uncommon in HD clinical spectrum.
Objective:
To determine the prevalence of cerebellar ataxia in patients with HD, both in the early and in the late stages of HD.
Methods:
Seventy-two individuals considered eligible were assessed by two trained doctors, applying the Scale for Assessment and Rating of
Ataxia
(SARA) and Brief
Ataxia
Rating Scale (BARS) for
ataxia
, the Unified Huntington's Disease Rating Scale (UHDRS) and also, Barthel Index (BI), in order to evaluate functional capacity.
Results:
Fifty-one patients (70.8%) presented with clinical
ataxia
at the time of examination (mean time of disease was 9.1 years). Six (8.33%) patients presented with cerebellar ataxia as first symptom. When stratified according to time of disease, a decline in the presence of chorea (
p
= 0.032) and an increase in
cognitive deficit
(
p
= 0.023) were observed in the patients as the disease progressed. The presence of
ataxia
was associated with longer duration of illness and severity of illness (UHDRS) (
p
< 0.0001), and shorter Barthel (less functionality) (
p
= 0.001).
Conclusions:
Cerebellar involvement may play an important role in natural history of brain degeneration in HD. The presence of cerebellar ataxia in HD is relevant and it may occur even in early stages, and should be included as part of the motor features of the disease.
...
PMID:Is Ataxia an Underestimated Symptom of Huntington's Disease? 3328 7
<< Previous
1
2
3